|
A retrospective series of centralized reviewed GEP MANECs receiving a first-line adenocarcinoma-oriented chemotherapy. |
| |
|
Honoraria - Ipsen; Novartis; Pfizer/EMD Serono |
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer |
| |
|
|
Travel, Accommodations, Expenses - Novartis |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - Novartis |
| |
|
Travel, Accommodations, Expenses - Novartis |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - Novartis |
| |
|
Travel, Accommodations, Expenses - Novartis |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |